Evidence map›Paper›PMID 32886488›Full record

ArticleAnalytical chemistry2020

Site-Specific Glycosylation Mapping of Fc Gamma Receptor IIIb from Neutrophils of Individual Healthy Donors.

Iwona Wojcik, Thomas Sénard, Erik L de Graaf, George M C Janssen, Arnoud H de Ru, Yassene Mohammed, Peter A van Veelen, Gestur Vidarsson, Manfred Wuhrer, David Falck

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Iwona WojcikCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0002-9365-1616
Thomas SénardCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0001-5951-4127
Erik L de GraafDepartment of Experimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
George M C JanssenCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Arnoud H de RuCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Yassene MohammedCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0003-3265-3332
Peter A van VeelenCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Gestur VidarssonDepartment of Experimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Manfred WuhrerCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0002-0814-4995
David FalckCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0003-3908-2376
Leiden University Medical Center · NLAmsterdam UMC Location University of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fc gamma receptors (FcγRs) translate antigen recognition by immunoglobulin G (IgG) into various immune responses. A better understanding of this key element of immunity promises novel insights into mechanisms of (auto-/allo-)immune diseases and more rationally designed antibody-based drugs. Glycosylation on both IgG and FcγR impacts their interaction dramatically. Regarding FcγR glycosylation profiling, major analytical challenges are associated with the presence of multiple glycosylation sites in close proximity and large structural heterogeneity. To address these challenges, we developed a straightforward and comprehensive analytical methodology to map FcγRIIIb glycosylation in primary human cells. After neutrophil isolation and immunoprecipitation, glycopeptides containing a single site each were generated by a dual-protease in-gel digestion. The complex mixture was resolved by liquid chromatography-tandem mass spectrometry (LC-MS/MS) providing information on the level of individual donors. In contrast to recently published alternatives for FcγRIIIb, we assessed its site-specific glycosylation in a single LC-MS/MS run and simultaneously determined the donor allotype. Studying FcγRIIIb derived from healthy donor neutrophils, we observed profound differences as compared to the soluble variant and the homologous FcγRIIIa on natural killer cells. This method will allow assessment of differences in FcγRIII glycosylation between individuals, cell types, subcellular locations, and pathophysiological conditions.

Indexed as

Protein Interaction MappingChromatography, LiquidGlycosylationGPI-Linked ProteinsHealthy VolunteersHumansNeutrophilsReceptors, IgGTandem Mass SpectrometryFCGR3B protein, humanGPI-Linked ProteinsReceptors, IgG

Identifiers

PMID32886488
PMCPMC7547861
OpenAlexW3083431551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.